Skip to main content
. Author manuscript; available in PMC: 2022 Oct 6.
Published in final edited form as: Lancet HIV. 2022 Jul 28;9(9):e607–e616. doi: 10.1016/S2352-3018(22)00166-7

Table 1:

Characteristics of districts participating in intervention and control groups

Intervention Control

Number of clusters 7 7
Number of districts 43 39
Number of managers 86 77
 District health officers 43 38
 District tuberculosis supervisors 43 39
Sex of managers
 Male 78(91%) 71 (92%)
 Female 8 (9%) 6 (8%)
Regions
 Southwest 13 12
 East 12 11
 East-central 18 16
Number of districts per randomisation cluster 5(5–6) 5(5–6)
Number of adults in active HIV care at the district level 5182 (2340–8346) 3456 (1949–8260)
Number of adults in active HIV care at the two largest clinics in each district 2099 (1270–3304) 1897 (1181–3378)
HIV prevalence: proportion of adults in HIV care among the total adult population in each district 4·7% (1·8–6·2) 2·3% (1·7–5·0)
IPT uptake*: proportion of adults in HIV care at the two largest clinics who had received IPT in the quarter immediately preceding the measurement period 1·8% (0·4–5·2) 2·2% (0·6–5·3)
Active tuberculosis prevalence: proportion of adults with tuberculosis disease diagnosis among adults in active HIV care at the district level in the quarter immediately preceding the measurement period 0·4% (0·3–0·6) 0·3% (0·2–0·4)

Data are n, n (%), or median (IQR). Randomisation was conducted within pairs of clusters matched on region, number of adults in HIV care, presence of large urban centres, and presence of a community that had participated from 2013 to 2017 in the SEARCH universal HIV test-and-treat trial. IPT=isoniazid preventive therapy.

*

Missing data on four clinics.

Missing data on two districts.